fouremm - I'm not holding my breath either.   Nevertheless, since that prediction is coming from me you probably should. :)

It's a mystery to me that the company was able to put together a P3 trial for some 2400 people worldwide but now they can't get their foot in the door for a measly 100 people infected with Covid to take a drug that is been proven to be perfectly safe.  I don't know what kind of issues the company's CRO (is that the agent they use to start dosing?) is facing but at the very least I expect we will get an answer on that tomorrow.  Even if they can't get dosing started in Canada then what about the other countries (Brazil, Morocco, etc.)?  Again, maybe we'll get some clarity on that tomorrow.

As for BoM2, the spread of Omicron is not helpful to getting that started.  The ideal scenario would be for ABL to deliver a sucker punch knockout blow to Covid and then BoM2 would get started very very quickly.  Now wouldn't that be nice!